Product Overview
Piracetam (2-Oxo-1-pyrrolidineacetamide) is a cyclic derivative of the neurotransmitter GABA and serves as the founding member of the Racetam family of compounds. First synthesized by Dr. Corneliu Giurgea in 1964, it is the molecule for which the term "nootropic" was originally coined.
In laboratory research, Piracetam is utilized as the primary benchmark for investigating the modulation of ionotropic glutamate receptors and the enhancement of cerebral metabolic activity.
Research Specifications:
- Chemical Formula: C₆H₁₀N₂O₂
- Molecular Weight: 142.16 g/mol
- Purity: > 99%+ USP Pharmaceutical Grade
- Form: Crystalline White Powder
- Solubility: Highly soluble in water and polar solvents
- Melting Point: 151.5 - 152.5 °C / 304.7 - 306.5 °F
- LogP: 1.54
- Storage Conditions: Dry conditions. Do not store above 25 °C / 77 °F
Primary Research Applications:
- Membrane Fluidity Studies: Researchers utilize Piracetam to observe its impact on the physical properties of neuronal membranes, specifically its ability to restore fluidity in aged or damaged cellular models.
- AMPA/NMDA Modulation: It is a key subject in studies focusing on the positive allosteric modulation of glutamate receptors, which are vital for Long-Term Potentiation (LTP).
- Cerebral Hemodynamics: Investigated for its role in increasing oxygen and glucose consumption in brain tissues without acting as a stimulant or sedative.
Research Notice: This compound is provided in pure powder form strictly for laboratory research, analysis, and developmental use. It is not for human or animal consumption.
